Robert Pelley
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 21
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Surgical Treatments 4
- Cancer Treatment and Pharmacology 4
-
- Ubiquitin and proteasome pathways 3
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Eren Berber (2 shared papers)Allan Siperstein (2 shared papers)Mark E. Baker (1 shared paper)H J Kung (5 shared papers)Hui‐Kuo G. Shu (7 shared papers)Ronald M. Bukowski (10 shared papers)Ronald P. Pelley (4 shared papers)Kenneth S. Warren (4 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer (5 papers)Journal of Virology (3 papers)Investigational New Drugs (3 papers)Molecular and Cellular Biology (2 papers)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Robert Pelley
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Hepatology 322
- Oncology 543
- Parasitology 111
- Pulmonary and Respiratory Medicine 384
- Otorhinolaryngology 40
Countries citing papers authored by Robert Pelley
This map shows the geographic impact of Robert Pelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pelley more than expected).
Fields of papers citing papers by Robert Pelley
This network shows the impact of papers produced by Robert Pelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pelley. The network helps show where Robert Pelley may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Pelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 205 | |
| 2 | 1993 | 132 | |
| 3 | 2003 | 120 | |
| 4 | 1995 | 94 | |
| 5 | 2015 | 68 | |
| 6 | Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. | 1985 | 63 |
| 7 | Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. | 1976 | 63 |
| 8 | 2008 | 61 | |
| 9 | 1990 | 48 | |
| 10 | 1997 | 46 | |
| 11 | 2000 | 45 | |
| 12 | 2013 | 43 | |
| 13 | 1976 | 41 | |
| 14 | 2000 | 37 | |
| 15 | 2013 | 33 | |
| 16 | 2001 | 31 | |
| 17 | 1999 | 31 | |
| 18 | 1997 | 29 | |
| 19 | 1989 | 29 | |
| 20 | 1988 | 28 |
About Robert Pelley
Robert Pelley is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Ubiquitin and proteasome pathways (3 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Hepatology (322 citations), Oncology (543 citations), Parasitology (111 citations), Pulmonary and Respiratory Medicine (384 citations) and Otorhinolaryngology (40 citations). Robert Pelley has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Eren Berber, Allan Siperstein, Mark E. Baker, H J Kung, Hui‐Kuo G. Shu, Ronald M. Bukowski, Ronald P. Pelley, Kenneth S. Warren, Joseph Hamburger and Pierre Peters. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Virology, Investigational New Drugs and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.